Melanoma vaccine (AVAX Technologies)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMelanoma vaccine (AVAX Technologies)
Drug Alias NameDNP-VACC黑素瘤疫苗 - AVAX Technologies黑色素瘤疫苗 - AVAX TechnologiesM-Vax黑瘤疫苗 - AVAX Technologies +[6] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMelanoma
Global Approved IndicationsMelanoma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryAustralia
Original Approved Date2000/01/01
Country/TerritoryUnited StatesAustraliaSwitzerland
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAvax Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesAvax Technologies Inc
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeL03AX12
Related LinksN/A